Heidi Turner has been a contributor since 2006. As a freelance writer, she has had her work published in various news outlets and magazines. In her spare time, Heidi entertains her four cats and travels as much as her budget allows. You can visit Heidi at www.heiditurner.ca
Minneapolis, MN: Current and former employees of Merrill Lynch & Co. are investigating a possible lawsuit against the company, alleging it violated the Employee Retirement Income Security Act of 1974 (ERISA). Those who would be affected by the potential lawsuit are participants and beneficiaries of the Merrill Lynch Employee Stock Ownership Plan.
Omaha, NE: A class action [lawsuit] has been filed against ConAgra Foods on behalf of all people who purchased or ate the company's pot pies that have been linked to a massive recall. The suit includes anyone who became sick after eating the pies.
Washington, DC: Lawmakers are rushing to pass bills that would ban lead from toys and other products that children under the age of six normally use. The bills follow recent recalls of Mattel toys that were contaminated with lead-based paint. In proposing the bills, the representatives noted that lead is not only unsafe for children it is also unnecessary, a sentiment that many parents agree with.
Oakland, CA: Some cell phone companies allegedly try to extend contracts or enforce new ones without the customer's knowledge. An angry customer posted a letter to Foodconsumer.org, detailing his troubles with Sprint PCS cell phone service. The reader notes that he recently received a letter from the cell phone carrier informing him that he has a new contract with Sprint beginning June 16, 2007 and ending June 16, 2009.
Oakland, CA: Plaintiffs in a class action lawsuit against T-Mobile have been given the go-head to continue with a lawsuit after a California court found an arbitration agreement customers had with T-Mobile was unconscionable and unenforceable. The suit alleges that T-Mobile's rules surrounding early termination fees and cell phone locking constituted unfair business practices.
Seattle, WA: Zelnorm, a drug manufactured to treat irritable bowel syndrome, is now being recalled internationally. China is the latest country to issue a recall, announcing last month that it had ordered domestic companies to stop making and selling Zelnorm and warning patients not to take the drug. In the U.S., patients who have taken Zelnorm and suffered adverse reactions are now investigating the possibility of filing lawsuits against Novartis.
San Francisco, CA: A recent study has found that for-profit dialysis centers are over-using anti-anemia drug Epogen, putting patients at risk of suffering deadly side effects.